Tradercommunity Clickoptions Forum

[Newsagent]

PR inside: First Patient Enrolled in US PRESERVE CAP Study for XVIVO Heart Assist ...

(PR-inside.com) GOTHENBURG, SE / ACCESS Newswire / July 21, 2025 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announces that the first patient has been enrolled as part of the Continued Access Protocol (CAP) study for its heart technology, XVIVO Heart Assist Transport, in the United States. This CAP study follows the successful PRESERVE Trial and allows for the enrollment of up to 60 patients across 26 US transplant centers. Importantly, the study has received continued cost recovery approval from the Centers for Medicare & Medicaid Services (CMS), providing essential access and support for both participating centers and patients.

The CAP, approved ..

https://reports.pr-inside.com/first-pat ... 121146.htm
Copyright PR-Inside.com 2025